BCLI Logo

Brainstorm Cell Therapeutics Inc. (BCLI) 

NASDAQ
Market Cap
$27.42M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
349 of 809
Rank in Industry
214 of 445

Largest Insider Buys in Sector

BCLI Stock Price History Chart

BCLI Stock Performance

About Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Insider Activity of Brainstorm Cell Therapeutics Inc.

Over the last 12 months, insiders at Brainstorm Cell Therapeutics Inc. have bought $20,402 and sold $0 worth of Brainstorm Cell Therapeutics Inc. stock.

On average, over the past 5 years, insiders at Brainstorm Cell Therapeutics Inc. have bought $254,023 and sold $504,774 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Lindborg Stacy (Co-Chief Executive Officer) — $20,402.

The last purchase of 11,500 shares for transaction amount of $20,402 was made by Lindborg Stacy (Co‑Chief Executive Officer) on 2023‑09‑01.

List of Insider Buy and Sell Transactions, Brainstorm Cell Therapeutics Inc.

2023-09-01PurchaseLindborg StacyCo-Chief Executive Officer
11,500
0.0277%
$1.77$20,402-78.20%
2020-07-16SaleACC International Holdings Ltd.
7,823
0.0252%
$13.47$105,351-62.10%
2020-07-16PurchaseSetboun DavidEVP and COO
5,000
0.0155%
$12.95$64,740-62.10%
2020-07-15SaleACC International Holdings Ltd.
18,430
0.06%
$13.12$241,715-60.36%
2020-07-15PurchaseAbbhi Sankeshdirector
46,779
0.1507%
$12.99$607,659-60.36%
2020-07-13SaleACC International Holdings Ltd.
40,000
0.1354%
$13.52$540,952-59.56%
2020-07-10SaleACC International Holdings Ltd.
2,000
0.0065%
$13.35$26,700-60.83%
2020-07-09SaleACC International Holdings Ltd.
3,500
0.0112%
$13.13$45,939-60.59%
2019-12-24PurchaseKern Ralph Dr.COO and Chief Medical Officer
3,000
0.0104%
$3.88$11,640+85.06%
2019-12-24PurchaseShah PreetamEVP, CFO and Treasurer
11,600
0.0409%
$3.96$45,929+85.06%
2019-12-24PurchaseAraya ArturoChief Commercial Officer
3,000
0.0104%
$3.90$11,700+85.06%
2019-08-28SaleARBEL IRITdirector
13,332
0.0592%
$3.67$48,891+29.65%
2019-01-04PurchaseAlmenoff June Sheriedirector
1,475
0.0071%
$3.39$5,000+15.43%
2018-03-15PurchaseKern Ralph Dr.COO and Chief Medical Officer
5,000
0.0276%
$3.60$17,997+9.06%
2018-03-15PurchaseAlmenoff June Sheriedirector
5,700
0.0306%
$3.50$19,950+9.06%
2017-08-31PurchaseARBEL IRITdirector
2,500
0.0133%
$4.26$10,650-6.92%
2017-08-23PurchaseYablonka UriEVP & Chief Business Officer
2,000
0.0104%
$3.98$7,960-2.69%
2015-12-16SaleSHORR ROBERT G Ldirector
10,800
0.0576%
$2.71$29,268-13.41%
2015-12-15SaleTAUB MALCOLM Sdirector
11,263
0.0598%
$2.59$29,171-9.81%
2015-12-14SaleTAUB MALCOLM Sdirector
30,479
0.1669%
$2.61$79,550-7.72%

Insider Historical Profitability

<0.0001%
Lindborg StacyCo-Chief Executive Officer
181500
0.3705%
$0.3910
ACCBT Corp.10 percent owner
7075000
14.4442%
$0.3950<0.0001%
Abbhi Sankeshdirector
2164530
4.4191%
$0.3910
Javitt Jonathan Cdirector
460000
0.9391%
$0.3909
ARBEL IRITdirector
155833
0.3181%
$0.3911<0.0001%
FRANKENBERGER MIKE
155000
0.3164%
$0.3932
STOLICK DAVIDChief Financial Officer
150000
0.3062%
$0.3904
Kern Ralph Dr.COO and Chief Medical Officer
115655
0.2361%
$0.3920+9.06%
ACC International Holdings Ltd.
67053
0.1369%
$0.39145<0.0001%
Setboun DavidEVP and COO
55000
0.1123%
$0.3910
Bibring YoramChief Financial Officer
50000
0.1021%
$0.3920<0.0001%
Shah PreetamEVP, CFO and Treasurer
36600
0.0747%
$0.3910
SHORR ROBERT G Ldirector
28399
0.058%
$0.39013
TAUB MALCOLM Sdirector
8666
0.0177%
$0.39022
Araya ArturoChief Commercial Officer
8608
0.0176%
$0.3910
Yablonka UriEVP & Chief Business Officer
7543
0.0154%
$0.3910<0.0001%
Almenoff June Sheriedirector
7175
0.0146%
$0.3920+12.25%
Fiorino Anthony S.Chief Executive Officer
2500
0.0051%
$0.3940<0.0001%
Friedman Mordechaidirector
0
0%
$0.3901

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$791,140.0021.4M-1.57%-$12,602.40<0.0001
BlackRock$276,315.000.7489,313+4.92%+$12,964.38<0.0001
Geode Capital Management$201,711.000.51357,0410%+$0<0.0001
Liberty Wealth Management Llc$192,000.000.49340,1500%+$00.05
Weaver Consulting Group$112,577.000.28199,3560%+$00.05
Caldwell Sutter Capital Inc$00.22157,0090%+$0<0.0001
Abner, Herrman & Brock Asset Management$82,000.000.21145,500New+$82,000.000.01
Raymond James Associates$64,254.000.16113,785-1.73%-$1,129.39<0.0001
Gsa Capital Partners Llp$63,000.000.16111,234New+$63,000.000.01
State Street$54,245.000.1496,0600%+$0<0.0001
Ikarian Capital LLC$50,960.000.1390,2420%+$00.02
Jmac Enterprises Llc$36,948.000.0965,4300%+$00.01
Northern Trust$30,939.000.0854,7880%+$0<0.0001
Morgan Stanley$22,643.000.0640,098-22.07%-$6,410.94<0.0001
Group One Trading$17,310.000.0430,654+27.5%+$3,733.16<0.01
Wells Fargo$16,438.000.0429,110-2.58%-$435.94<0.0001
Susquehanna International Group$14,989.000.0426,544+6.9%+$967.30<0.0001
Creative Planning$12,269.000.0321,726+3.38%+$400.95<0.0001
Janney Montgomery Scott LLC$12,000.000.0320,5000%+$0<0.0001
Jane Street Capital$10,578.000.0318,732New+$10,578.00<0.0001
Professional Financial Advisors Llc$9,757.000.0317,2790%+$0<0.01
First Affirmative Financial Network$8,627.000.0215,278-2.71%-$239.980.01
Nelson Van Denburg & Campbell Wealth Management Group LLC$7,163.000.0212,6860%+$0<0.0001
BNY Mellon$6,772.000.0211,9940%+$0<0.0001
Tower Research Capital$6,218.000.0211,005-39.65%-$4,085.63<0.0001
Advisor Group Holdings Inc$5,890.000.0210,519-2.05%-$123.19<0.0001
Cypress Capital Management Llc Wy$5,647.000.0110,0000%+$00.01
Institutional Family Asset Management Llc$3,388.000.016,0000%+$0<0.01
Bangor Savings Bank$2,259.000.014,0000%+$0<0.0001
Simplex Trading Llc$2,000.000.014,039New+$2,000.00<0.0001
Steward Partners Investment Advisory LLC$2,372.000.014,2000%+$0<0.0001
UBS$1,413.00<0.012,5000%+$0<0.0001
EverSource Wealth Advisors$581.00<0.012,1280%+$0<0.0001
VisionPoint Advisory Group$1,098.00<0.011,9440%+$0<0.0001
Clearstead Advisors Llc$822.00<0.011,500New+$822.00<0.0001
St Germain D J Co Inc$282.00<0.015000%+$0<0.0001
Bank of America$564.00<0.011,000-5.12%-$30.46<0.0001
Cranbrook Wealth Management Llc$565.00<0.011,000New+$565.00<0.0001
Royal Bank of Canada$0<0.01317-41.73%-$0<0.0001
MARK SHEPTOFF FINANCIAL PLANNING, LLC$56.00<0.011000%+$0<0.0001
JPMorgan Chase$60.00<0.01106+49.3%+$19.81<0.0001
Westside Investment Management Inc$112.00<0.012000%+$0<0.0001